全文获取类型
收费全文 | 12846篇 |
免费 | 742篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 404篇 |
妇产科学 | 235篇 |
基础医学 | 1783篇 |
口腔科学 | 419篇 |
临床医学 | 1180篇 |
内科学 | 2379篇 |
皮肤病学 | 128篇 |
神经病学 | 1401篇 |
特种医学 | 372篇 |
外科学 | 1848篇 |
综合类 | 71篇 |
一般理论 | 8篇 |
预防医学 | 1020篇 |
眼科学 | 265篇 |
药学 | 1008篇 |
1篇 | |
中国医学 | 21篇 |
肿瘤学 | 947篇 |
出版年
2023年 | 51篇 |
2022年 | 84篇 |
2021年 | 178篇 |
2020年 | 163篇 |
2019年 | 224篇 |
2018年 | 264篇 |
2017年 | 225篇 |
2016年 | 242篇 |
2015年 | 271篇 |
2014年 | 347篇 |
2013年 | 595篇 |
2012年 | 769篇 |
2011年 | 798篇 |
2010年 | 459篇 |
2009年 | 423篇 |
2008年 | 724篇 |
2007年 | 751篇 |
2006年 | 745篇 |
2005年 | 710篇 |
2004年 | 670篇 |
2003年 | 647篇 |
2002年 | 632篇 |
2001年 | 204篇 |
2000年 | 167篇 |
1999年 | 199篇 |
1998年 | 158篇 |
1997年 | 140篇 |
1996年 | 123篇 |
1995年 | 141篇 |
1994年 | 117篇 |
1993年 | 106篇 |
1992年 | 133篇 |
1991年 | 142篇 |
1990年 | 108篇 |
1989年 | 108篇 |
1988年 | 120篇 |
1987年 | 114篇 |
1986年 | 104篇 |
1985年 | 131篇 |
1984年 | 123篇 |
1983年 | 88篇 |
1982年 | 117篇 |
1981年 | 99篇 |
1980年 | 55篇 |
1979年 | 65篇 |
1978年 | 74篇 |
1977年 | 75篇 |
1975年 | 51篇 |
1974年 | 52篇 |
1973年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
2.
3.
4.
5.
6.
Ulla Bergfeldt Kristian Borg Kjell Kullander Per Julin 《Journal of rehabilitation medicine》2006,38(3):166-171
OBJECTIVE: Analysis of the effects of a comprehensive focal spasticity program in adult patients. DESIGN: Retrospective study of an out-patient cohort. PATIENTS: One hundred patients were enrolled in the study (54 men and 46 women, mean age 41 years (SD 14). Cerebral palsy and stroke were equally common (80% in total). The remaining patients had miscellaneous diagnoses, including traumatic brain injury. METHODS: On average 230 units (SD 101) of botulinum toxin A Botox was given for 227 principal therapy targets chosen by the patient or the caregiver. One patient could have several targets for therapy. Administration of botulinum toxin was combined with 260 additional therapeutic interventions, most of which were forms of physical therapy. The effects were assessed after 6 weeks and compared with baseline functional abilities 1-2 weeks prior to therapy. RESULTS: Improvement was observed for 211 (93%) therapy targets, no change in 15 (7%), and impairment in 1, corresponding to an overall improvement in 90 patients (90%), 9 unchanged (9%) and worsening in 1. Spasticity assessment (Ashworth scale 0-4; 30 patients) showed a statistically significant improvement (median at baseline was 3 vs 2 after therapy, mean difference 1.2, p<0.001). CONCLUSION: Improvement was observed in >or=90% of patients and in their principal therapeutic targets in a cohort receiving their first focal spasticity treatment with botulinum toxin A and additional therapy. A strict strategy for patient selection and comprehensive management was followed. 相似文献
7.
8.
9.
Birgitta Malmberg Göran Kecklund Björn Karlson Roger Persson Per Flisberg Palle Ørbaek 《BMC health services research》2010,10(1):239
Background
It is well known that physicians' night-call duty may cause impaired performance and adverse effects on subjective health, but there is limited knowledge about effects on sleep duration and recovery time. In recent years occupational stress and impaired well-being among anaesthesiologists have been frequently reported for in the scientific literature. Given their main focus on handling patients with life-threatening conditions, when on call, one might expect sleep and recovery to be negatively affected by work, especially in this specialist group. The aim of the present study was to examine whether a 16-hour night-call schedule allowed for sufficient recovery in anaesthesiologists compared with other physician specialists handling less life-threatening conditions, when on call. 相似文献10.